Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemiaLinde Dekker, Stefan Nierkens, Peter M. Hoogerbrugge et al.|Blood Advances|2022Cited by 89
Case Report: Lessons Learned From Subsequent Autologous and Allogeneic Hematopoietic Stem Cell Transplantations in a Pediatric Patient With Relapsing PolychondritisSaskia R Veldkamp, Caroline A. Lindemans, Marc H.A. Jansen et al.|Frontiers in Immunology|2022Cited by 5
Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomesSusanna P.C. Höppener, Marc H.A. Jansen, Saskia R Veldkamp et al.|Clinical Immunology Communications|2025Cited by 2
Predictors for Persistent Hypogammaglobulinemia After Rituximab Therapy in Pediatric PatientsSusanna P.C. Höppener, Marc H.A. Jansen, Saskia R Veldkamp et al.|Research Square|2024Cited by 0